Lisata Therapeutics (LSTA) vs Tempest Therapeutics (TPST)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Lisata Therapeutics (LSTA) has outperformed Tempest Therapeutics (TPST) over the past year, losing 52.6% versus a loss of 92.6%. Over five years, LSTA leads with a -93.6% price change compared with -99.6% for TPST. Tempest Therapeutics is the larger company by market cap ($13.4 million vs $12.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LSTA | TPST |
|---|---|---|
| Share price | $1.17 | $0.7914 |
| Market cap | $12.64M | $13.37M |
| 1-day change | -3.31% | +0.50% |
| YTD return | -37.10% | -72.43% |
| 1-year return | -52.63% | -92.63% |
| 5-year return | -93.61% | -99.59% |
| EPS (TTM) | $-1.57 | $-3.98 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.07 | $12.23 |
| 52-week low | $0.99 | $0.743 |
| Distance from 52-week high | -76.92% | -93.53% |
| Average volume | 291.98K | 2.63M |
| Shares outstanding | 10.80M | 16.89M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LSTA has outperformed TPST by 40.0 percentage points over the past year.
LSTA vs TPST FAQ
Which is bigger, Lisata Therapeutics or Tempest Therapeutics?
Tempest Therapeutics (TPST) is larger, with a market capitalization of $13.37M compared with $12.64M for Lisata Therapeutics (LSTA).
Which stock has performed better over the past year, LSTA or TPST?
LSTA returned -52.63% over the past 12 months, compared with -92.63% for TPST (price return, excluding dividends). Past performance does not predict future results.
Are Lisata Therapeutics and Tempest Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.